Therapeutic Approach

Archive: September, 2009

Ritter Pharmaceuticals’ CEO, Andrew J. Ritter to Present at the 11th Annual SoCalBio Investor and Partnership Conference

LOS ANGELES — September 10, 2009 — Ritter Pharmaceuticals, Inc. (Ritter), a leader in gastrointestinal health, announced today that the Company’s President and Chief Executive Officer, Andrew J. Ritter, will be presenting at the 11th Annual SoCalBio Investor and Partnership Conference. The Conference is being held Thursday, September 17, 2009 at The Loews Santa Monica […]

Leave Your Comments »

Ritter Pharma Hires Dr. Howard Foyt

Ritter Pharmaceuticals Hires Dr. Howard Foyt as Executive Vice President, Development & Chief Medical Officer LOS ANGELES–September 9, 2009–Ritter Pharmaceuticals, Inc (Ritter) has hired Howard Foyt, M.D., Ph.D., FACP as its new Executive VP, Development & Chief Medical Officer. Dr. Foyt brings 13 years of expertise in drug development to Ritter, as the Company prepares […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD